StockData
Enveric Biosciences, Inc. logo

Enveric Biosciences, Inc. (ENVB) stock

ENVBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 6/30
$1.41−0.03 (-2.08%)

Close on Nov 17, 2026Market cap $6.31MP/E –Yield –

Enveric Biosciences profit margin

Profit margin (net margin) is net income as a percentage of revenue.

Enveric Biosciences's profit margin for the twelve months ending Sep 30, 2020 was -5.1%. For fiscal 2019 it was -6.0%, against -39.3% the year before. The highest annual figure on record is -4.0% in fiscal 2015.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2019Dec 31, 2019-6.0%+33.3
FY2018Dec 31, 2018-39.3%−20.6
FY2017Dec 31, 2017-18.7%−11.0
FY2016Dec 31, 2016-7.7%−3.7
FY2015Dec 31, 2015-4.0%–

Quarterly profit margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q3 FY2020Sep 30, 2020-6.7%−7.1
Q2 FY2020Jun 30, 2020-9.9%+1.5
Q1 FY2020Mar 31, 2020-11.4%+6.0
Q4 FY2019Dec 31, 20197.3%+199.5
Q3 FY2019Sep 30, 20190.5%−53.4
Q2 FY2019Jun 30, 2019-11.4%−0.0
Q1 FY2019Mar 31, 2019-17.4%−3.2
Q4 FY2018Dec 31, 2018-192.2%−183.4
Q3 FY2018Sep 30, 201853.9%+86.4
Q2 FY2018Jun 30, 2018-11.4%+15.4
Q1 FY2018Mar 31, 2018-14.2%−8.4
Q4 FY2017Dec 31, 2017-8.8%−19.3
Q3 FY2017Sep 30, 2017-32.5%−14.8
Q2 FY2017Jun 30, 2017-26.7%–
Q1 FY2017Mar 31, 2017-5.9%–
Q4 FY2016Dec 31, 201610.5%–
Q3 FY2016Sep 30, 2016-17.7%–

More Enveric Biosciences figures

See a number that looks wrong?